Advisory Committees Vote for Co-Prescribing Labeling for Naloxone

Drug Industry Daily
A A
Two FDA advisory committees voted 12-11 on Tuesday in favor of language on opioid labels that recommends co-prescribing of naloxone.

To View This Article:

Login

Subscribe To Drug Industry Daily